Nystatin
Candex, Mycostatin, Nilstat, Nysert (nystatin) is a small molecule pharmaceutical. Nystatin was first approved as Candex on 1982-01-01. It is used to treat chronic mucocutaneous candidiasis, cutaneous candidiasis, mycoses, oral candidiasis, and vulvovaginal candidiasis in the USA.
| Trade Name | Candex, Mycostatin, Nilstat, Nysert |
|---|---|
| Common Name | Nystatin |
| Indication | chronic mucocutaneous candidiasis, cutaneous candidiasis, mycoses, oral candidiasis, vulvovaginal candidiasis |
| Drug Class | Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors) |
